Samsung的WELT在2026年CES推出AI动力药物系统,使用QR码通过生物鉴别学和睡眠数据将通用药物个人化。 Samsung's WELT launches AI-powered drug system at CES 2026, using QR codes to personalize generic meds via biometrics and sleep data.

WELT是三星的副产品,在2026年CES启动了AI-Combo药物平台,引进了第一个AI强化药物系统,该系统使用QR编码将非专利药物转化为个性化疗法。 WELT, a Samsung spin-off, launched its AI-Combo Drug platform at CES 2026, introducing the first AI-enhanced medication system that uses a QR code to transform generic drugs into personalized therapies. 该系统通过分析睡眠数据、生物鉴别学和生活方式因素,预测失眠事件,并建议最佳避孕药时间,以提高效果和减少副作用。 By analyzing sleep data, biometrics, and lifestyle factors, the system predicts insomnia episodes and recommends optimal pill timing to boost effectiveness and reduce side effects. 该技术在不改变其化学特性的情况下对现有非专利药物进行升级,为药物制造者延长产品生命周期提供了符合监管规定的方式。 The technology upgrades existing generics without altering their chemistry, offering a regulatory-compliant way for drugmakers to extend product life cycles. 该平台最初以睡眠为重点, 有可能用于焦虑、疼痛、哮喘及妇女健康, 随着美国、韩国及德国全球扩张, Initially focused on sleep, the platform has potential for use in anxiety, pain, asthma, and women’s health, with global expansion underway in the U.S., Korea, and Germany.